CNO Financial Group Q3 2026 earnings

CNO · 2026-10-29 16:20 AMC ET · 8-K on SEC

Operating earnings per share grew 47% in the quarter, and the company raised full-year operating EPS guidance by 9% at the midpoint.

Headline numbers

MetricActualYoYQoQ8-K location
Net income$161 million+75.2%+27.9%Ex. 99.1, income statement

Revenue breakdown

not stated in the 8-K

Margins and costs

  • Gross margin not stated in the 8-K
  • Operating expenses not stated in the 8-K
  • One-offs in the quarter Comprehensive annual actuarial review: $44.9 million net favorable impact on both net income and net operating income; Valuation allowance on deferred tax assets: $22.1 million; TechMod initiative: $10.1 million expense; Mark-to-market change in agent deferred compensation plan liability: $10.0 million; Goodwill and other asset impairment: $96.7 million (3Q25)
  • Effective tax rate not stated in the 8-K
  • Non-GAAP bridge Net operating income excludes non-operating items (non-economic accounting impacts, investment losses, market value changes, embedded derivative liabilities, TechMod, goodwill impairment, divested business losses, and valuation allowance). Significant items (actuarial review) are added back to GAAP net operating income.

KPIs

MetricActualPrior quarterPrior yearChange
Insurance policy income$688.2 million$680.7 million$658.4 million+1.1%
Net investment income (general account)$441.5 million$411.9 million$378.3 million+16.5%
Insurance product margin (Total)$333 million$279 million$300.5 million+10.9%
Annuity margin$87.9 million$60.6 million$54.8 million+44.9%
Life margin$96 million$71.2 million$63.6 million+50.8%
Realized investment losses$48.3 million$14.7 million$18.4 million+229.6%
Embedded derivative liabilities and market risk benefits+$69.7 million+$34.6 million+$25.2 million+101.2%

Guidance

MetricGuidePrior guideChange
Operating earnings per share (full-year)Raised by 9% at the midpoint from prior guidancePrior guidance (from 2Q26 release)+9%

What drove it

  • Revenue story Insurance policy income increased 1.1% year-over-year to $688.2 million; net investment income from general account assets grew 16.5% to $441.5 million.
  • EPS story Operating EPS grew 47% year-over-year to $1.90, driven by higher insurance product margins and favorable embedded derivative valuations.
  • One-off check Comprehensive annual actuarial review: $44.9 million net favorable impact on both net income and net operating income.

The good

  • Operating EPS grew 47% in the quarter and 43% year-to-date
  • Operating ROE (excluding significant items) of 14.1%
  • Total new annualized premiums (NAP) up for a 17th consecutive quarter
  • Book value per diluted share, excluding AOCI, up 8% year-to-date

The bad

  • Realized investment losses increased to $48.3 million
  • Net change in market value of investments recognized in earnings decreased to -$16.4 million

The ugly

  • none

Open questions

  • The magnitude of the valuation allowance on deferred tax assets ($22.1 million) and its impact on future earnings
  • The specific drivers of the $69.7 million increase in embedded derivative liabilities and market risk benefits
Full release

Earnings: CNO — filed 2026-10-29

CNO Financial Group, Inc. (CNO) · Form 8-K, Item 2.02 · Filed · SEC filing

News

CNO Financial Group Reports Third Quarter 2026 Results

Carmel, Ind., October 29, 2026 -

CNO Financial Group, Inc. (NYSE: CNO) today reported its third quarter 2026 financial results:

• Raising 2026 operating earnings per share (EPS) guidance with the midpoint up 9% from our prior guidance.

• Net income was $161 million, or $1.71 per diluted share, and net operating income

Financial statements

Income Statement

(Unaudited)

1Q – 20252Q – 20253Q – 20254Q – 2025YTD – 20251Q – 20262Q – 20263Q – 2026
Revenues
Insurance policy income650.7651.3658.4662.22,622.6673.4680.7688.2
Net investment income:
General account assets375.1378.3382.9406.11,542.4395411.9441.5
Policyholder and other special-purpose portfolios-63.6105.4116.822.4181-64.9185.16.1
Investment gains (losses):
Realized investment losses-3.8-21.3-12.9-21.6-59.6-7.8-8.6-32.6
Other investment (losses) gains-32.99.9-4.94.9-14.9-6.1-32.1
Total investment losses-6.8-18.4-3-26.5-54.7-22.7-14.7-64.7
Fee revenue and other income48.734.933.678.9196.148.822.214.9
Total revenues1,004.11,151.51,188.71,143.14,487.41,029.61,285.21,086
Benefits and expenses
Insurance policy benefits570658.4702.1617.72,548.2576.6742.5565.1
Liability for future policy benefits remeasurement gain-12.2-12.8-30.8-14.9-70.7-6.5-15.3-52.5
Change in fair value of market risk benefits15.3-10.9-12.4-4.4-12.410.7-8.3-28.8
Interest expense6259.156.653.2230.950.955.358.1
Amortization of deferred acquisition costs and present value of future profits67.468.669.972.127874.274.976.8
Goodwill and other asset impairment96.75.2101.9
Gain on extinguishment related to VIEs-1.5-1.5
Other operating costs and expenses275.3271.1270.4302.81,119.6275.3276.4240.9
Total benefits and expenses976.31,033.51,152.51,031.74,194981.21,125.5859.6
Income before income taxes27.811836.2111.4293.448.4159.7226.4
Income tax expense6.326.213.118.564.110.733.865.3
Net income21.591.823.192.9229.337.7125.9161.1

Income Statement

(Unaudited)

1Q – 20252Q – 20253Q – 20254Q – 2025YTD – 20251Q – 20262Q – 20263Q – 2026
Insurance product margin (4)
Annuity margin54.554.872.956.4238.658.560.687.9
Health margin126.2134157139.4556.6132.6147.2149.1
Life margin68.263.670.670272.465.871.296
Total insurance product margin248.9252.4300.5265.81,067.6256.9279333
Allocated expenses-161.2-149.4-151-149.7-611.3-159.9-152.9-161
Income from insurance products (8)87.7103149.5116.1456.397126.1172
Fee income-0.80.8-3.919.115.210.6-1.2-1.1
Investment income not allocated to product lines (9)3833.839.558.1169.441.749.468.1
Expenses not allocated to product lines-20.3-25.3-22.3-19.8-87.7-19.4-23.3-18.8
Operating earnings before taxes104.6112.3162.8173.5553.2129.9151220.2
Tax expense on operating income-23.5-24.8-35.6-30.1-114-28.6-31.5-41.1
Net operating income (10)81.187.5127.2143.4439.2101.3119.5179.1
Net realized investment losses from disposals, impairments and change in allowance for credit losses-13.2-21.8-8.8-25.2-69-15.2-13.6-48.3
Net change in market value of investments recognized in earnings6.43.45.8-1.314.3-7.5-1.1-16.4
Fair value changes related to agent deferred compensation plan-1.7-1.710
Changes in fair value of embedded derivative liabilities and market risk benefits-69.625.2-18.1-1.5-64-42.434.669.7
Expenses related to TechMod initiative-3.2-7.2-9.9-20.3-13.7-9.7-10.1
Goodwill and other asset impairment-96.7-5.2-101.9
Net loss related to divested business-17.3-17.3-1.9-1.1
Other-0.42.1-1.60.1-0.8-0.41.3
Net non-operating income (loss) before taxes-76.85.7-126.6-62.1-259.8-81.58.76.2
Income tax expense:
On non-operating income (loss)17.2-1.422.511.649.917.9-2.3-2.1
Valuation allowance for deferred tax assets-22.1
Net non-operating income (loss)-59.64.3-104.1-50.5-209.9-63.66.4-18
Net income21.591.823.192.9229.337.7125.9161.1
Per diluted share
Net operating income0.790.871.291.474.41.051.261.9
Net non-operating income (loss)-0.580.04-1.05-0.52-2.1-0.660.07-0.19
Net income0.210.910.240.952.30.391.331.71

Income Statement

(Unaudited)

1Q – 20252Q – 20253Q – 2025 (a)4Q – 2025YTD – 20251Q – 20262Q – 20263Q – 2026 (b)
Net gain from operations before interest expense and federal income taxes2937.745.295.3207.237.462.942.9
Interest expense on surplus debentures held by parent company15.515.729.415.375.914.414.514.8
Net gain from operations before federal income taxes13.52215.880131.32348.428.1
Federal income tax expense (benefit)20.961.682.5136.2
Net gain (loss) from operations before net realized capital gains (losses)13.522-5.118.448.82335.421.9
Net realized capital losses-1.2-2.6-11.1-48.5-63.4-1.5-16.4-3.5
Net income (loss)12.319.4-16.2-30.1-14.621.51918.4
Capital and surplus1,422.31,417.81,403.11,405.31,405.31,399.11,413.61,418.3
Asset valuation reserve (AVR)428.5459.3485508.7508.7534.2566.1601.5
Capital, surplus and AVR1,850.81,877.11,888.11,9141,9141,933.31,979.72,019.8
Interest maintenance reserve (IMR)331.5315.8298.3252.6252.6246.2243.6226.9
Total statutory capital, surplus, AVR & IMR2,182.32,192.92,186.42,166.62,166.62,179.52,223.32,246.7

Income Statement

(Unaudited)

1Q – 20252Q – 20253Q – 20254Q – 2025YTD – 20251Q – 20262Q – 20263Q – 2026
Excluding variable components:
From general account assets2824.120.632.310523.423.524.3
Other investment income10.96.61.83.222.53.231.9
Federal Home Loan Bank ("FHLB") program:
Investment income35.436.640.637.8150.436.942.646.6
Interest expense (a)-26-27.7-29.7-27.8-111.2-25.9-30.3-33.3
Net spread income on FHLB program9.48.910.91039.21112.313.3
Funding agreement-backed notes ("FABN") program:
Investment income34.336.937.642.9151.746.549.352.3
Expenses (a)(b)-27.9-27.7-29.1-32.9-117.6-36.7-37.5-40.7
Net spread income on FABN program6.49.28.51034.19.811.811.6
Interest expense on corporate debt (a)-27.2-24.6-20.3-20.4-92.5-20.3-20.4-20.4
Interest expense on financing arrangements (a)-1-1-0.8-0.9-3.7-0.7-0.7-0.6
Total excluding variable components26.523.220.734.2104.626.429.530.1
Net income from assets supporting deferred compensation plans:
Investment income-2.11511.34.628.8-5.917.5-0.3

Income Statement

Three months ended

Three months ended – September 30, 2026 – Actual resultsThree months ended – September 30, 2026 – Significant itemsThree months ended – September 30, 2026 – Excluding significant items
Insurance product margin (4)
Annuity margin87.9-20.567.4
Health margin149.1-7.8141.3
Life margin96-2868
Total insurance product margin333-56.3276.7
Allocated expenses-161-161
Income from insurance products (5)172-56.3115.7
Fee income-1.1-1.1
Investment income not allocated to product lines (9)68.168.1
Expenses not allocated to product lines-18.8-18.8
Operating earnings before taxes220.2-56.3163.9
Income tax (expense) benefit on operating income-41.111.4-29.7
Net operating income (10)179.1-44.9134.2
Net operating income per diluted share1.9-0.481.42

Income Statement

Three months ended

Three months ended – September 30, 2025 – Actual resultsThree months ended – September 30, 2025 – Significant itemsThree months ended – September 30, 2025 – Excluding significant items
Insurance product margin (4)
Annuity margin72.9-16.656.3
Health margin157-21.1135.9
Life margin70.6-3.667
Total insurance product margin300.5-41.3259.2
Allocated expenses-151-151
Income from insurance products (5)149.5-41.3108.2
Fee income-3.9-3.9
Investment income not allocated to product lines (9)39.539.5
Expenses not allocated to product lines-22.3-22.3
Operating earnings before taxes162.8-41.3121.5
Income tax (expense) benefit on operating income-35.69.1-26.5
Net operating income (10)127.2-32.295
Net operating income per diluted share1.29-0.330.96

Income Statement

Three months ended

Three months ended – March 31, 2025 – Actual resultsThree months ended – March 31, 2025 – Significant itemsThree months ended – March 31, 2025 – Excluding significant items
Insurance product margin (4)
Annuity margin54.554.5
Health margin126.2126.2
Life margin68.2-6.861.4
Total insurance product margin248.9-6.8242.1
Allocated expenses-161.2-161.2
Income from insurance products (5)87.7-6.880.9

Income Statement

Per diluted share – Quarter ended – September 30, – 2026Per diluted share – Quarter ended – September 30, – 2025Per diluted share – Quarter ended – September 30, – % changeQuarter ended – September 30, – 2026Quarter ended – September 30, – 2025Quarter ended – September 30, – % change
Income from insurance products (b)1.831.5220.0%172149.515.0%
Fee income-0.01-0.04-75.0%-1.1-3.9-72.0%
Investment income not allocated to product lines (c)0.720.480.0%68.139.572.0%
Expenses not allocated to product lines-0.2-0.23-13.0%-18.8-22.3-16.0%
Operating earnings before taxes2.341.65220.2162.8
Income tax expense on operating income-0.44-0.3622.0%-41.1-35.615.0%
Net operating income (1)1.91.2947.0%179.1127.241.0%
Net realized investment losses from disposals, impairments and change in allowance for credit losses-0.51-0.09-48.3-8.8
Net change in market value of investments recognized in earnings-0.170.06-16.45.8
Changes in fair value of embedded derivative liabilities and market risk benefits0.74-0.1869.7-18.1
Expenses related to TechMod initiative-0.11-0.07-10.1-7.2
Goodwill and other asset impairment-0.98-96.7
Other0.11-0.0211.3-1.6
Non-operating income before taxes0.06-1.286.2-126.6
Income tax expense:
On non-operating income-0.020.23-2.122.5
Valuation allowance for deferred tax assets-0.23-22.1
Net non-operating income-0.19-1.05-18-104.1
Net income1.710.24161.123.1
Weighted average diluted shares outstanding94.398.6

Income Statement

Quarter ended — ___________________________________________________________________________________________________

Quarter ended – September 30, – 2026Quarter ended – September 30, – 2025
Net Income417.6319.3
Net operating income (a non-GAAP financial measure)543.3433.8
Net operating income, excluding significant items (a non-GAAP financial measure)498.4399.4
Average of each of the trailing four quarters average:
Shareholders’ equity2,548.92,560.6
Accumulated other comprehensive loss1,211.91,245.2
Shareholders’ equity, excluding accumulated other comprehensive loss3,760.83,805.8
Net operating loss carryforwards-238.1-225.8
Shareholders' equity, excluding accumulated other comprehensive loss and net operating loss carryforwards3,522.73,580
Ratios:
Return on equity16.412.5
Operating return on equity (a non-GAAP financial measure) (5)15.412.1
Operating return on equity, excluding significant items (a non-GAAP financial measure) (5)14.111.2

Income Statement

Three months ended — (unaudited)

Three months ended – September 30, – 2026Three months ended – September 30, – 2025Nine months ended – September 30, – 2026Nine months ended – September 30, – 2025
Revenues:
Insurance policy income688.2658.42,042.31,960.4
Net investment income:
General account assets441.5382.91,248.41,136.3
Policyholder and other special-purpose portfolios6.1116.8126.3158.6
Investment gains (losses):
Realized investment losses-32.6-12.9-49-38
Other investment (losses) gains-32.19.9-53.19.8
Total investment losses-64.7-3-102.1-28.2
Fee revenue and other income14.933.685.9117.2
Total revenues1,0861,188.73,400.83,344.3
Benefits and expenses:
Insurance policy benefits565.1702.11,884.21,930.5
Liability for future policy benefits remeasurement gain-52.5-30.8-74.3-55.8
Change in fair value of market risk benefits-28.8-12.4-26.4-8
Interest expense58.156.6164.3177.7
Amortization of deferred acquisition costs and present value of future profits76.869.9225.9205.9
Goodwill and other asset impairment96.796.7
Gain on extinguishment of borrowings related to variable interest entities-1.5
Other operating costs and expenses240.9270.4792.6816.8
Total benefits and expenses859.61,152.52,966.33,162.3
Income before income taxes226.436.2434.5182
Income tax expense65.313.1109.845.6
Net income161.123.1324.7136.4
Basic:
Weighted average shares outstanding92,195,00096,603,00093,156,00098,639,000
Net income1.750.243.491.38

Income Statement

Trailing four quarters — A reconciliation of pre-tax operating earnings (a non-GAAP financial measure) to net income is as follows (dollars in millions):

Trailing four quarters – 3Q26Trailing four quarters – 3Q25
Pre-tax operating earnings (a non-GAAP financial measure)674.6553.6
Income tax expense-131.3-119.8
Net operating income543.3433.8
Non-operating items:
Net realized investment losses from disposals, impairments and change in allowance for credit losses-102.3-78.9
Net change in market value of investments recognized in earnings-26.39
Changes in fair value of embedded derivative liabilities and market risk benefits60.430.1
Fair value changes related to the agent deferred compensation plan8.36.6
Expenses related to TechMod initiative-43.4-10.4
Goodwill and other asset impairment-5.2-96.7
Net loss related to divested business-20.3
Other0.10.8
Non-operating loss before taxes-128.7-139.5
Income tax (expense) benefit:
Income tax benefit on non-operating loss25.125
Valuation allowance for deferred tax assets-22.1
Net non-operating loss-125.7-114.5
Net income417.6319.3

Income Statement

Trailing four quarter average (in millions)

Trailing four quarter average – 3Q26Trailing four quarter average – 3Q25
Consolidated capital, excluding accumulated other comprehensive
3,522.73,580
Net operating loss carryforwards238.1225.8
Accumulated other comprehensive loss-1,211.9-1,245.2
Common shareholders' equity2,548.92,560.6

Income Statement

Three months ended (dollars in millions, except per share data)

Three months ended – September 30, 2026 – Actual resultsThree months ended – September 30, 2026 – Significant itemsThree months ended – September 30, 2026 – Excluding significant items
Insurance product margin
Annuity margin87.9-20.567.4
Health margin149.1-7.8141.3
Life margin96-2868
Total insurance product margin333-56.3276.7
Allocated expenses-161-161
Income from insurance products172-56.3115.7
Fee income-1.1-1.1
Investment income not allocated to product lines68.168.1
Expenses not allocated to product lines-18.8-18.8
Operating earnings before taxes220.2-56.3163.9
Income tax (expense) benefit on operating income-41.111.4-29.7
Net operating income179.1-44.9134.2

Income Statement

Three months ended — Comprised of $56.3 million of the net favorable impact arising from our comprehensive annual actuarial review.

Three months ended – September 30, 2025 – Actual resultsThree months ended – September 30, 2025 – Significant itemsThree months ended – September 30, 2025 – Excluding significant items
Insurance product margin
Annuity margin72.9-16.656.3
Health margin157-21.1135.9
Life margin70.6-3.667
Total insurance product margin300.5-41.3259.2
Allocated expenses-151-151
Income from insurance products149.5-41.3108.2
Fee income-3.9-3.9
Investment income not allocated to product lines39.539.5
Expenses not allocated to product lines-22.3-22.3
Operating earnings before taxes162.8-41.3121.5
Income tax (expense) benefit on operating income-35.69.1-26.5
Net operating income127.2-32.295
Net operating income per diluted share1.29-0.330.96

Income Statement

Three months ended — Comprised of $41.3 million of the net favorable impact arising from our comprehensive annual actuarial review.

Three months ended – March 31, 2025 – Actual resultsThree months ended – March 31, 2025 – Significant itemsThree months ended – March 31, 2025 – Excluding significant items
Insurance product margin
Annuity margin54.554.5
Health margin126.2126.2
Life margin68.2-6.861.4
Total insurance product margin248.9-6.8242.1
Allocated expenses-161.2-161.2
Income from insurance products87.7-6.880.9
Fee income-0.8-0.8
Investment income not allocated to product lines3838
Expenses not allocated to product lines-20.3-20.3
Operating earnings before taxes104.6-6.897.8
Income tax (expense) benefit on operating income-23.51.5-22
Net operating income81.1-5.375.8
Net operating income per diluted share0.79-0.050.74

Balance Sheet

(Unaudited)

Mar-25Jun-25Sep-25Dec-25Mar-26Jun-26Sep-26
Investments:
Fixed maturities, available for sale, at fair value23,28323,04723,405.323,886.823,881.124,495.723,677.6
Equity securities at fair value349.1387.4377.2389.2332.8337.2328
Mortgage loans2,601.22,834.33,042.73,256.83,347.83,356.33,437.1
Policy loans136.4137.6141.2140.9141.8144.2145.6
Trading securities308308.3296.9294.8280.2258.6234
Investments held by variable interest entities380.2376.9296.8293287.4292.3307.8
Other invested assets1,386.71,500.51,6171,7371,695.11,858.61,912
Total investments28,444.628,59229,177.129,998.529,966.230,742.930,042.1
Cash and cash equivalents - unrestricted928.27661,218.3956.11,129.51,289.71,409.4
Cash and cash equivalents held by variable interest entities96.65023.327.424.816.312
Accrued investment income289.6279.4282286284.2302.5302.3
Present value of future profits156.5152.1147.8143.6139.5135.5131.7
Deferred acquisition costs2,209.92,276.32,343.72,397.32,441.32,508.12,570.3
Reinsurance receivables3,804.33,753.93,731.73,677.53,611.13,568.53,479.9
Income tax assets, net768749.3708.1713.3748.9709.7759.8
Assets held in separate accounts3.12.92.72.82.732.9
Other assets728.4707.2661.5588.1615.2585596.3
Total assets37,429.237,329.138,296.238,790.638,963.439,861.239,306.7
Liabilities for insurance products:
Policyholder account balances17,314.317,60918,290.318,912.618,997.319,640.919,819.3
Future policy benefits11,77311,787.711,975.511,89811,722.211,784.710,988.3
Market risk benefit liability73.663.852.648.158.150.621.9
Liability for life insurance policy claims63.560.761.558.458.861.863
Unearned and advanced premiums221.5217.3214.5228225.2219227.2
Liabilities related to separate accounts3.12.92.72.82.732.9
Other liabilities1,027.2935.81,036.9952.81,098.6957.11,047
Investment borrowings2,188.62,441.72,441.72,441.72,691.72,941.73,191.7
Borrowings related to variable interest entities375.1352.8274.3274.4274.4274.5285
Notes payable - direct corporate obligations1,834.21,334.71,335.21,335.61,3361,336.31,336.7

Income Statement (in millions)

Net operating – incomeSignificant – itemsNet operating – income, – excluding – significant – items (a)Net operating – income, – excluding – significant – items - trailing – four quartersNet – income (loss)Net – income - – trailing – four quarters
4Q241383.1141.1410.5182.9420.8
1Q2581.1-5.375.8428.821.5330
2Q2587.587.5401.791.8305.5
3Q25127.2-32.295399.423.1319.3
4Q25143.4143.4401.792.9229.3
1Q26101.3101.3427.237.7245.5
2Q26119.5119.5459.2125.9279.6
3Q26179.1-44.9134.2498.4161.1417.6

Income Statement (in millions)

1Q241Q242Q242Q243Q243Q244Q244Q24
(a non-GAAP financial measure)3,536.83,596.73,529.93,810
Net operating loss carryforwards311.2296.5273.976.6
Accumulated other comprehensive loss-1,480.3-1,464.3-1,116-1,371.4
Common shareholders' equity2,367.72,428.92,687.82,515.2
Consolidated capital, excluding accumulated other comprehensive
(a non-GAAP financial measure)3,498.93,504.33,483.63,510.2
Net operating loss carryforwards295.3271.1246.3243
Accumulated other comprehensive loss-1,239.1-1,252.7-1,118.9-1,115
Common shareholders' equity2,555.12,522.72,6112,638.2
(a non-GAAP financial measure)3,461.23,548.53,658.3
Net operating loss carryforwards254.8225.9211.2
Accumulated other comprehensive loss-1,217.6-1,182.8-1,545.8
Common shareholders' equity2,498.42,591.62,323.7

(1) was $179 million, or $1.90 per diluted share. Significant items related to the comprehensive annual actuarial review had a $44.9 million net favorable impact on both net income and net operating income.

• Operating EPS grew 47% in the quarter and 43% year-to-date.

• Return on equity (ROE) of 16.4%; Operating ROE

(5) of 14.1%, excluding significant items

(5).

• Book value per share of $25.34; Book value per diluted share, excluding accumulated other comprehensive loss,

(2) of $41.29, up 8%.

• Total new annualized premiums (NAP)

(4) up for a 17 th consecutive quarter; Continued growth in asset accumulation products.

• Consumer and Worksite delivered their 15 th and 17 th consecutive quarters of producing agent count growth, respectively.

• On October 1, 2026, closed a 3 rd reinsurance transaction with CNO’s wholly owned Bermuda affiliate, reinsuring approximately $270 million of inforce graded benefit life statutory reserves from Colonial Penn.

“CNO delivered an excellent quarter, with operating earnings per share up 47% and our 17 th consecutive quarter of sales growth,” said Gary C. Bhojwani, chief executive officer.

“Our momentum reflects disciplined execution across the business and continued improvement in profitability. Based on these results, we are raising our full-year operating earnings per share guidance. We also executed our 3 rd reinsurance transaction with our Bermuda affiliate, supporting our focus on serving middle-income households. We remain committed to driving sustained, profitable growth and creating long-term value for our shareholders.”

FINANCIAL SUMMARY

Quarter End

(Amounts in millions, except per share data)

(Unaudited)

Net operating income, a non-GAAP

(a) financial measure, is used consistently by CNO’s management to evaluate the operating performance of the Company and is a measure commonly used in the life insurance industry. It differs from net income primarily because it excludes the non-operating items as defined in note (1), which are primarily non-economic accounting impacts and other non-operating items. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.

Significant items positively impacted both net income and net operating income

(1) by $44.9 million, or $0.48 per diluted share, in 3Q26 compared to $32.2 million, or $0.33 per diluted share, in 3Q25. Significant items are detailed in note (6).

____________________

(a) GAAP is defined as accounting principles generally accepted in the United States of America.

(b) Income from insurance products is the sum of the insurance product margins of the annuity, health and life product lines, less expenses allocated to the insurance product lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes. Insurance product margin is management’s measure of the profitability of its annuity, health and life product lines’ performance and consists of insurance policy income plus allocated investment income less insurance policy benefits, interest credited, commissions, advertising expense and amortization of acquisition costs.

(c) Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable, investment borrowings and financing arrangements; (iv) expenses related to the funding agreement-backed notes ("FABN") program; and (v) certain expenses related to benefit plans that are offset by special-purpose investment income; plus (vi) the impact of annual option forfeitures related to fixed indexed annuity surrenders. Investment income not allocated to product lines includes investment income on investments in excess of amounts allocated to product lines, investments held by our holding companies, the spread we earn from our Federal Home Loan Bank ("FHLB") investment borrowing and FABN programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from company-owned life insurance ("COLI") and alternative investment income not allocated to product lines), net of interest expense on corporate debt and financing arrangements. The spread earned from our FHLB investment borrowing and FABN programs includes the investment income on the matched assets less: (i) interest on investment borrowings related to the FHLB investment borrowing program; (ii) interest credited on funding agreements; and (iii) amortization of deferred acquisition costs related to the FABN program.²

FINANCIAL SUMMARY (continued)

Management vs. GAAP Measures

(Dollars in millions, except per share data)

(Unaudited)... (truncated)o hold investments to maturity and meaningful trends can be more easily identified without the fluctuations. In addition, shareholders' equity excludes net operating loss carryforwards in our non-GAAP return on equity measures as such assets are not discounted and, accordingly, will not provide a return to shareholders until after it is realized as a reduction to taxes that would otherwise be paid. Management believes that excluding this value from the equity component of this measure enhances the understanding of the effect these non-discounted assets have on operating returns.

___________________________________________________________________________________________________³

Non-Operating Items

Net realized investment losses in 3Q26 were $48.3 million, including the unfavorable change in the allowance for credit losses of $5.4 million. Net realized investment losses in 3Q25 were $8.8 million, including the favorable change in the allowance for credit losses of $8.0 million.

During 3Q26 and 3Q25, we recognized a decrease in earnings of $16.4 million and an increase of $5.8 million, respectively, due to the net change in market value of investments.

During 3Q26 and 3Q25, we recognized an increase in earnings of $69.7 million and a decrease of $18.1 million, respectively, resulting from changes in the estimated fair value of embedded derivative liabilities and market risk benefits related to our fixed indexed annuities. Such amounts include the impacts of changes in market interest rates and equity impacts used to determine the estimated fair values of the embedded derivatives and market risk benefits and the unfavorable impact resulting from our comprehensive annual actuarial review of $11.2 million and $14.3 million in 3Q26 and 3Q25, respectively.

During 3Q26 and 3Q25, we incurred $10.1 million and $7.2 million, respectively, of expense related to TechMod, our technology modernization initiative that began in 2025.

During 3Q26, other non-operating items primarily included a $10.0 million mark-to-market change in the agent deferred compensation plan liability, which was impacted by changes in the underlying actuarial assumptions used to value the liability. We recognize the mark-to-market change in the estimated value of this liability through earnings as assumptions change.

During 3Q25, we recognized a $96.7 million non-operating charge for the impairment of goodwill and other assets related to the acquisitions of Web Benefits Design and DirectPath in 2019 and 2021, respectively. This reflected macroeconomic uncertainty and market conditions including the decline in the value of comparable publicly traded companies and revised financial projections for the business.

During 3Q26, we recognized a $22.1 million valuation allowance on deferred tax assets associated with capital loss carryforwards. The valuation allowance reflects realized capital losses generated primarily from asset sales in anticipation of executing the internal reinsurance transaction on October 1, 2026, portfolio optimization activities, and from capital loss allocations from partnership investments together with a reduction in unrealized capital gains available to support realization of those losses as interest rates increased.

Statutory (based on non-GAAP measures) and GAAP Capital Information

The consolidated statutory risk-based capital ratio of our U.S. based insurance subsidiaries was estimated at 374% at September 30, 2026, reflecting estimated 3Q26 statutory operating gain of $21.9 million. There were no company dividends paid to the holding company during 3Q26.

During 3Q26, we repurchased $60.0 million of common stock under our securities repurchase program. We repurchased 1.1 million common shares at an average cost of $54.52 per share. As of September 30, 2026, we had 91.7 million shares outstanding and had authority to repurchase up to an additional $240.4 million of our common stock. During 3Q26, dividends paid on common stock totaled $16.5 million.

Unrestricted cash and investments held by our holding company were $230.7 million at September 30, 2026 compared to $351.4 million at December 31, 2025.

Book value per common share was $25.34 at September 30, 2026 compared to $27.92 at December 31, 2025. Book value per diluted share, excluding accumulated other comprehensive income (loss)

(2), was $41.29 at September 30, 2026 compared to $38.81 at December 31, 2025.

The debt-to-capital ratio was 36.5% and 33.6% at September 30, 2026 and December 31, 2025, respectively. Our debt-to-total capital ratio, excluding accumulated other comprehensive income (loss)

(3), was 25.7% and 26.2% at September 30, 2026 and December 31, 2025, respectively.

Return on equity for the trailing four quarters ended September 30, 2026 and 2025 was 16.4% and 12.5%, respectively. Operating return on equity, excluding significant items

(5), for the trailing four quarters ended September 30, 2026 and 2025 was 14.1% and 11.2%, respectively.

In this news release, CNO includes non-GAAP measures to enhance investors’ understanding of management’s view of the business. The non-GAAP measures are not a substitute for GAAP, but rather a supplement to increase transparency by providing a broader perspective. CNO’s definitions of non-GAAP measures may differ from other companies’ definitions. More detailed information including various GAAP and non-GAAP measurements are located at

CNOinc.com in the Investors section under SEC Filings.⁴

CAUTION REGARDING FORWARD-LOOKING STATEMENTS:... (truncated)equent Form 10-Q or Form 10-K on file with the Securities and Exchange Commission and on the Company’s website at

CNOinc.com in the Investors section. CNO specifically disclaims any obligation to update or revise any forward-looking statement because of new information, future developments or otherwise.

EARNINGS RELEASE CONFERENCE CALL WEBCAST:

The Company will host a conference call to discuss results on October 30, 2026 at 11:00 a.m. Eastern Time. During the call, we will be referring to a presentation that will be available at the Investors section of the company's website.

To participate by dial-in, please register at https://register-conf.media-server.com/register/BI92346cd8ec894d29bcfdf06f719c8513. Upon registering, you will be provided with call details and a unique PIN to join the call as well as an email confirmation with details.

For those investors who prefer to listen to the call online, we will be broadcasting the call live via webcast. The event can be accessed through the Investors section of the company's website: ir.CNOinc.com. Participants should go to the website at least 15 minutes before the event to register and download any necessary audio software.

ABOUT CNO FINANCIAL GROUP

CNO Financial Group, Inc. (NYSE: CNO) secures the future of middle-income America. CNO provides life and health insurance, annuities and financial services through our family of brands, including Bankers Life, Colonial Penn, Optavise and Washington National. Our customers work hard to save for the future, and we help protect their health, income and retirement needs with 3.3 million policies and $39.3 billion in total assets. Our 3,200 associates, 5,100 exclusive agents and more than 6,500 independent partner agents guide individuals, families and businesses through a lifetime of financial decisions. For more information, visit

CNOinc.com.⁵

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.